Top Section/Ad
Top Section/Ad
Most recent
DocMorris announces Sfr200m rights issue expected in May
Stock drops 17% in highly volatile market
Deal follows steep share price fall
More articles/Ad
More articles/Ad
More articles
-
Danish firm specialised in treatment for metabolic diseases issues 6.5m shares -
UK pharma latest high rated company to hit the euro market this week
-
Rise of mRNA technology was a gamechanger for the sector, says analyst
-
Vaccine maker issued shares in oversubscribed deal to fund acquisition
-
-
Existing shareholders took a large chunk of the deal, 30% of bidders left empty-handed
